And it was more significant than left ventricular ejection fraction, Charach and colleagues reported online in the American Journal of Cardiology.
And it was more significant than left ventricular ejection fraction, Charach and colleagues reported online in the American Journal of Cardiology.
CHICAGO — Cardiac resynchronization therapy (CRT) is just as good “off the shelf” as with customization of its timing by algorithm or echocardiography, researchers found.
In the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND HF), there was “no evidence for a major benefit” from nesiritide vs placebo on top of standard care, said Dr Robert Califf (Duke Clinical Research Institute, Durham, NC) at a presentation of the trial for the media. The trial was scheduled for formal presentation later in the day here at the American Heart Association 2010 Scientific Sessions by Dr Adrian F Hernandez (Duke Clinical Research Institute).